Candriam Equities L Oncology Impact R/ LU1864482788 /
| NAV5/6/2024 | Chg.+0.7700 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 279.0400USD | +0.28% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | - | - | - | - | - | - | - | - | - | - | - | -6.01 | - |
| 2019 | 10.23 | 6.17 | 2.65 | -3.66 | -2.58 | 8.68 | 0.29 | -0.29 | -3.18 | 5.10 | 7.95 | 5.04 | +41.40% |
| 2020 | -1.47 | -5.35 | -3.08 | 12.11 | 8.53 | 1.41 | 4.42 | 2.15 | 3.51 | -2.22 | 5.80 | 3.86 | +32.31% |
| 2021 | 0.54 | -4.21 | -0.10 | 2.32 | 0.17 | 3.52 | -0.97 | 5.57 | -3.78 | 3.37 | -6.38 | 3.98 | +3.33% |
| 2022 | -10.50 | -1.76 | 4.64 | -5.86 | -1.34 | 0.03 | 4.36 | -3.15 | -4.72 | 7.04 | 6.06 | -3.45 | -9.77% |
| 2023 | 2.15 | -3.89 | 1.38 | 2.82 | -2.57 | 0.08 | 0.88 | -2.03 | -5.25 | -6.37 | 9.21 | 5.72 | +1.01% |
| 2024 | 1.36 | 4.13 | 1.49 | -3.39 | 2.13 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 11.07% | 11.43% | 11.77% | 14.71% | 17.30% |
| Sharpe ratio | 1.23 | 2.93 | -0.07 | -0.19 | 0.33 |
| Best month | +5.72% | +9.21% | +9.21% | +9.21% | +12.11% |
| Worst month | -3.39% | -3.39% | -6.37% | -10.50% | -10.50% |
| Maximum loss | -6.78% | -6.78% | -16.12% | -25.23% | -25.23% |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,334.9600 | +3.50% | +4.40% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,494.9500 | +3.63% | +4.79% | |
| Candriam Equities L Oncology Imp... | reinvestment | 202.4600 | +0.05% | -6.33% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,206.4399 | +3.59% | +14.19% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,567.1899 | +3.17% | +3.40% | |
| Candriam Equities L Oncology Imp... | reinvestment | 240.7800 | +4.42% | +12.44% | |
| Candriam Equities L Oncology Imp... | paying dividend | 229.8800 | +2.21% | +0.53% | |
| Candriam Equities L Oncology Imp... | paying dividend | 186.0900 | +3.07% | +3.10% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,279.0000 | -0.10% | +0.69% | |
| Candriam Equities L Oncology Imp... | reinvestment | 156.1000 | +3.47% | +13.80% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,057.8301 | +0.99% | -3.65% | |
| Candriam Equities L Oncology Imp... | reinvestment | 255.0400 | +5.30% | +15.31% | |
| Candriam Equities L Oncology Imp... | reinvestment | 201.9900 | -0.35% | -7.43% | |
| Candriam Equities L Oncology Imp... | reinvestment | 279.0400 | +3.07% | +3.08% | |
| Candriam Equities L Oncology Imp... | reinvestment | 189.0100 | +0.88% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,819.7200 | +3.92% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,805.1799 | +3.17% | +3.40% | |
| Candriam Equities L Oncology Imp... | reinvestment | 154.8300 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 267.0800 | +2.21% | +0.51% |
Performance
| YTD | +5.68% | ||
|---|---|---|---|
| 6 Months | +17.03% | ||
| 1 Year | +3.07% | ||
| 3 Years | +3.08% | ||
| 5 Years | +57.28% | ||
| Since start | +86.03% | ||
| Year | |||
| 2023 | +1.01% | ||
| 2022 | -9.77% | ||
| 2021 | +3.33% | ||
| 2020 | +32.31% | ||
| 2019 | +41.40% | ||
